In Depth 1 Apr 2025
The biggest biotech funding rounds in March 2025
The companies Isomorphic Labs, DBV Technologies, and Genfit bagged the biggest biotech funding rounds overall in March 2025.
In Depth
- Latest Posts
In Depth 26 Mar 2025
A guide to kinase inhibitors in biotech: From cancer breakthroughs to autoimmune innovations
Delve into the kinase inhibitors’ diverse landscape, from cancer breakthroughs to autoimmune disease innovations.
In Depth 19 Mar 2025
Breast cancer treatments heat up: Five therapies poised to transform patient outcomes
Find out more about the overall breast cancer treatment landscape, as biotech companies make progress with different approaches.
In Depth 17 Mar 2025
How biotechs are using AI to rescue failed drugs
Discover how biotech companies like Ignota Labs and BioXcel Therapeutics are using AI to rescue failed drugs.
In Depth 14 Mar 2025
Can GLP-1 agonists help treat addiction?
Discover how researchers have been exploring the potential of GLP-1 drugs for treating addiction disorders.
In Depth 12 Mar 2025
Checkpoint inhibitors in cancer: breakthroughs, setbacks, and what’s next
Checkpoint inhibitors are drugs that harness the immune system to destroy cancer cells. Let us review what’s been going on in the field.
ADVERTISEMENT
ADVERTISEMENT
In Depth 11 Mar 2025
The gender gap in clinical trials: Why women are still underrepresented
Find out what led biotech to a situation where women are underrepresented in clinical trials and how the industry is correcting it.
In Depth 7 Mar 2025
Catalonia: A biotech hub going from strength to strength, with Barcelona at its core
Take a deeper look at Catalonia’s biotech sector and overall life sciences hub, including the key drivers behind its success.
In Depth 4 Mar 2025
The biggest biotech funding rounds in February 2025
The companies Eikon Therapeutics, Sionna Therapeutics, and Abcuro bagged the biggest biotech funding rounds overall in February 2025.
In Depth 26 Feb 2025
New non-opioid pain medication: How is the biotech industry fighting pain after the opioid crisis?
Find out how biotechs are fighting pain with new non-opioid pain medication, as they look to overcome the ongoing opioid crisis.
In Depth 21 Feb 2025
The future of organ transplants: Xenotransplantation, 3D bioprinting and stem cells
Discover how biotech could solve the organ shortage crisis through xenotransplantation, 3D bioprinting and stem cells.
In Depth 18 Feb 2025
T cell engagers: A promising, fast-growing field for cancer and autoimmune disease treatments
T cell engagers represent a novel approach to tuning the immune system to target and kill tumor cells, expanding treatment options for cancer.
ADVERTISEMENT
